APA

PAYNE R. W., SHETLAR M. R., FARR C. H., HELLBAUM A. A. & ISHMAEL W. K. (20030501). The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). : The Journal of laboratory and clinical medicine.

Chicago

PAYNE R W, SHETLAR M R, FARR C H, HELLBAUM A A and ISHMAEL W K. 20030501. The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). : The Journal of laboratory and clinical medicine.

Harvard

PAYNE R. W., SHETLAR M. R., FARR C. H., HELLBAUM A. A. and ISHMAEL W. K. (20030501). The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). : The Journal of laboratory and clinical medicine.

MLA

PAYNE R W, SHETLAR M R, FARR C H, HELLBAUM A A and ISHMAEL W K. The value of phenylbutazone in the treatment of rheumatoid arthritis as determined by clinical response and by the serum protein-polysaccharide ratio (PR). : The Journal of laboratory and clinical medicine. 20030501.